Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Vitekta
Elvitegravir (Vitekta) is an oral HIV antiretroviral (ARV) medication; however, it's no longer available as a tablet on its own because it was discontinued.
Last reviewed on November 16, 2021
What is Elvitegravir (Vitekta)?
How Elvitegravir (Vitekta) works
Drug Facts
Common BrandsVitekta
Drug ClassHIV ARV
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityDiscontinued
Pharmacist tips for Elvitegravir (Vitekta)
Frequently asked questions about Elvitegravir (Vitekta)
What is elvitegravir (Vitekta)?
Elvitegravir (Vitekta) is an HIV ARV integrase inhibitor. It prevents HIV from inserting itself into your DNA. This way, the virus can't grow and spread in your body.
Is elvitegravir (Vitekta) still available?
Why was elvitegravir (Vitekta) discontinued?
Gilead, the manufacturer, stopped making elvitegravir (Vitekta) tablets in 2017. They chose to stop making the stand-alone tablet since most people take HIV ARV combination tablets. Their decision had nothing to do with safety of the medication.
How to save using GoodRx
1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
Get savings updates for Elvitegravir (Vitekta)
Receive price alerts, news, and other messages from GoodRx about Elvitegravir (Vitekta) and other healthcare topics and relevant savings offers.By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Browse medications
View AllResearch prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.